CO2023017195A2 - Inhibidores unidos a c de yeats enl/af9 - Google Patents
Inhibidores unidos a c de yeats enl/af9Info
- Publication number
- CO2023017195A2 CO2023017195A2 CONC2023/0017195A CO2023017195A CO2023017195A2 CO 2023017195 A2 CO2023017195 A2 CO 2023017195A2 CO 2023017195 A CO2023017195 A CO 2023017195A CO 2023017195 A2 CO2023017195 A2 CO 2023017195A2
- Authority
- CO
- Colombia
- Prior art keywords
- yeats
- enl
- linked inhibitors
- compounds
- formula
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 206010000830 Acute leukaemia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Abstract
Se desvelan compuestos de Fórmula I y composiciones farmacéuticas que comprenden compuestos de Fórmula I. También se desvelan métodos para tratar leucemias agudas usando los compuestos de Fórmula I y composiciones farmacéuticas que comprenden los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163188426P | 2021-05-13 | 2021-05-13 | |
PCT/US2022/028516 WO2022240830A1 (en) | 2021-05-13 | 2022-05-10 | C-linked inhibitors of enl/af9 yeats |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2023017195A2 true CO2023017195A2 (es) | 2024-03-18 |
Family
ID=84028826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2023/0017195A CO2023017195A2 (es) | 2021-05-13 | 2023-12-12 | Inhibidores unidos a c de yeats enl/af9 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP4337662A1 (es) |
JP (1) | JP2024518824A (es) |
KR (1) | KR20240047955A (es) |
CN (1) | CN117858877A (es) |
AU (1) | AU2022272294A1 (es) |
BR (1) | BR112023023578A2 (es) |
CA (1) | CA3218317A1 (es) |
CO (1) | CO2023017195A2 (es) |
IL (1) | IL308430A (es) |
WO (1) | WO2022240830A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024054749A2 (en) * | 2022-09-08 | 2024-03-14 | Bridge Medicines | Inhibitors of enl/af9 yeats and flt3 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8642770B2 (en) * | 2010-01-06 | 2014-02-04 | Takeda Pharmaceutical Company Limited | Indole derivative |
EP2818472A1 (en) * | 2013-06-27 | 2014-12-31 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Imidazo[4,5-c]pyridine and pyrrolo[3,2-c]pyridine compounds as G-protein-coupled receptor kinase 5 (GRK5) modulators |
WO2021021904A1 (en) * | 2019-07-30 | 2021-02-04 | The Scripps Research Institute | Pharmacological inhibitors of the enl yeats domain |
KR102085692B1 (ko) * | 2019-08-13 | 2020-03-06 | 한양대학교 에리카산학협력단 | Flt3 저해 활성을 갖는 신규한 이미다졸 유도체 및 이의 용도 |
-
2022
- 2022-05-10 JP JP2023570355A patent/JP2024518824A/ja active Pending
- 2022-05-10 IL IL308430A patent/IL308430A/en unknown
- 2022-05-10 AU AU2022272294A patent/AU2022272294A1/en active Pending
- 2022-05-10 CN CN202280049574.0A patent/CN117858877A/zh active Pending
- 2022-05-10 BR BR112023023578A patent/BR112023023578A2/pt unknown
- 2022-05-10 WO PCT/US2022/028516 patent/WO2022240830A1/en active Application Filing
- 2022-05-10 EP EP22808174.1A patent/EP4337662A1/en active Pending
- 2022-05-10 KR KR1020237042506A patent/KR20240047955A/ko unknown
- 2022-05-10 CA CA3218317A patent/CA3218317A1/en active Pending
-
2023
- 2023-12-12 CO CONC2023/0017195A patent/CO2023017195A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA3218317A1 (en) | 2022-11-17 |
EP4337662A1 (en) | 2024-03-20 |
JP2024518824A (ja) | 2024-05-07 |
AU2022272294A1 (en) | 2023-11-30 |
BR112023023578A2 (pt) | 2024-03-12 |
KR20240047955A (ko) | 2024-04-12 |
WO2022240830A1 (en) | 2022-11-17 |
CN117858877A (zh) | 2024-04-09 |
IL308430A (en) | 2024-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2022000447A1 (es) | Inhibidores de kras g12d | |
CL2020000075A1 (es) | Carboxamidas como moduladores de los canales de sodio. | |
CL2021003477A1 (es) | Compuestos 2,3-dihidroquinazolin como inhibidores nav1 .8 | |
UY38076A (es) | Derivados de tetrahidroquinazolina útiles como agentes anticáncer | |
CO2020014009A2 (es) | Inhibidores de mcl-1 | |
CL2022001671A1 (es) | Inhibidores de sos1 | |
CO2021016018A2 (es) | Inhibidores de tead y usos de los mismos referencia cruzada a solicitudes relacionadas | |
CO2021016015A2 (es) | Inhibidores de tead y usos de los mismos referencia cruzada a solicitudes relacionadas | |
ECSP22046699A (es) | Inhibidores de kras g12c | |
CL2020002146A1 (es) | Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cáncer. | |
CO2018008759A2 (es) | Inhibidores de mcl-1 y métodos de uso de los mismos | |
CO2023017195A2 (es) | Inhibidores unidos a c de yeats enl/af9 | |
ECSP22052564A (es) | Tetrahidrofuranos sustituidos como moduladores de canales de sodio | |
CU20210080A7 (es) | Triazinas sustituidas como inhibidores de proteína tirosina fosfatasa | |
CO2018013077A2 (es) | Inhibidores de la arginasa y sus aplicaciones terapéuticas | |
CO6300939A2 (es) | Compuestos novedosos que son inhibidores de erk referencia a una solicitud relacionada | |
CL2008001743A1 (es) | Uso de un compuesto derivado de quinazolina para tratar el cancer; uso del compuesto y de otro compuesto antineoplasico; compuestos derivados de quinazolina; y composicion farmaceutica que los comprende. | |
UY39526A (es) | Inhibidores de kras g12d | |
CO2021000049A2 (es) | Inhibidores de ectonucleotidasa y métodos de uso de los mismos | |
CL2021001461A1 (es) | Moduladores de trex1 | |
CL2017002856A1 (es) | Compuestos de tioéter como inhibidores de la nitrificación | |
CL2020001534A1 (es) | Derivados de pirrol como inhibidores de acc. | |
CU20160148A7 (es) | Compuestos de azol sustituidos con amida como inhibidores de tnks1 y/o tnks2 | |
CL2022002402A1 (es) | Inhibidores del eif4e y sus usos | |
CL2021002521A1 (es) | Compuestos heteocíclicos y sus usos. |